CAE are pleased to announce a long-term agreement for the development and production of the next-generation mission trainer ...

Reflecting these positive developments, Goldman Sachs has raised its 12-month target price for Everest Medicines to HK$48.32, nearly doubling from the previous HK$24.50. The upgrade factors in ...